Overview
- 23 inspections across 21 sites are on record.
- 12 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-28.
At a glance
Inspections
23
Sites
21
Observations
12
Career since
Jan 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Syngene International Limited | 28 Feb 2020 | Human Drugs | |
| Jeevan Scientific Technology Limited | 24 Jan 2020 | Human Drugs | |
| Glenmark Pharmaceuticals Ltd | 17 Jan 2020 | Human Drugs | |
| Triumpharma Bioanalytical Lab | 12 Dec 2019 | Human Drugs | |
| BioAgilytix | 7 Jun 2019 | Human Drugs |
Sites inspected
Syngene International LimitedBengalore, India1 insp.
Jeevan Scientific Technology LimitedHyderabad, India1 insp.
Glenmark Pharmaceuticals LtdNavi Mumbai, India1 insp.
Triumpharma Bioanalytical LabAmman, Jordan1 insp.
BioAgilytixHamburg, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Amanda Lewin4 shared
Melkamu Getie Kebtie3 shared
Nicola M Fenty-Stewart3 shared
Hasan A Irier2 shared
Xikui Chen2 shared
Makini Cobourne-Duval2 shared
Ruben C Ayala2 shared
Gajendiran Mahadevan1 shared
Xiaohan Cai1 shared
Kara A Scheibner1 shared
Full investigator report
Get the verbatim findings behind Li-Hong Yeh's 12 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site